117 related articles for article (PubMed ID: 8801342)
1. Different properties of the paracellular pathway account for the regional small intestinal permeability to the peptide desmopressin.
Pantzar N; Lundin S; Weström BR
J Pharm Sci; 1995 Oct; 84(10):1245-8. PubMed ID: 8801342
[TBL] [Abstract][Full Text] [Related]
2. Differences in transport rate of oxytocin and vasopressin analogues across proximal and distal isolated segments of the small intestine of the rat.
Lundin S; Pantzar N; Broeders A; Ohlin M; Weström BR
Pharm Res; 1991 Oct; 8(10):1274-80. PubMed ID: 1796046
[TBL] [Abstract][Full Text] [Related]
3. Regional small-intestinal permeability in vitro to different-sized dextrans and proteins in the rat.
Pantzar N; Weström BR; Luts A; Lundin S
Scand J Gastroenterol; 1993 Mar; 28(3):205-11. PubMed ID: 7680488
[TBL] [Abstract][Full Text] [Related]
4. Enhancing effects of monohexanoin and two other medium-chain glyceride vehicles on intestinal absorption of desmopressin (dDAVP).
Lundin PD; Bojrup M; Ljusberg-Wahren H; Weström BR; Lundin S
J Pharmacol Exp Ther; 1997 Aug; 282(2):585-90. PubMed ID: 9262318
[TBL] [Abstract][Full Text] [Related]
5. Effects of enzymatic inhibition and increased paracellular shunting on transport of vasopressin analogues in the rat.
Ungell AL; Andreasson A; Lundin K; Utter L
J Pharm Sci; 1992 Jul; 81(7):640-5. PubMed ID: 1403696
[TBL] [Abstract][Full Text] [Related]
6. Bidirectional small-intestinal permeability in the rat to some common marker molecules in vitro.
Pantzar N; Lundin S; Wester L; Weström BR
Scand J Gastroenterol; 1994 Aug; 29(8):703-9. PubMed ID: 7526439
[TBL] [Abstract][Full Text] [Related]
7. Modulation of the permeability of H2 receptor antagonists cimetidine and ranitidine by P-glycoprotein in rat intestine and the human colonic cell line Caco-2.
Collett A; Higgs NB; Sims E; Rowland M; Warhurst G
J Pharmacol Exp Ther; 1999 Jan; 288(1):171-8. PubMed ID: 9862768
[TBL] [Abstract][Full Text] [Related]
8. Closed-Loop Doluisio (Colon, Small Intestine) and Single-Pass Intestinal Perfusion (Colon, Jejunum) in Rat-Biophysical Model and Predictions Based on Caco-2.
Lozoya-Agullo I; Gonzalez-Alvarez I; Zur M; Fine-Shamir N; Cohen Y; Markovic M; Garrigues TM; Dahan A; Gonzalez-Alvarez M; Merino-Sanjuán M; Bermejo M; Avdeef A
Pharm Res; 2017 Dec; 35(1):2. PubMed ID: 29288412
[TBL] [Abstract][Full Text] [Related]
9. Localisation of drug permeability along the rat small intestine, using markers of the paracellular, transcellular and some transporter routes.
Lacombe O; Woodley J; Solleux C; Delbos JM; Boursier-Neyret C; Houin G
Eur J Pharm Sci; 2004 Dec; 23(4-5):385-91. PubMed ID: 15567292
[TBL] [Abstract][Full Text] [Related]
10. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.
Dahan A; Amidon GL
Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal absorption and plasma clearance rates of [D-Arg8]vasopressin analogues in the rat.
Lundin S; Folkesson HG; Pierzynovski SG; Bengtsson HI
Peptides; 1994; 15(5):809-14. PubMed ID: 7984498
[TBL] [Abstract][Full Text] [Related]
12. Application of the MechPeff model to predict passive effective intestinal permeability in the different regions of the rodent small intestine and colon.
Pade D; Jamei M; Rostami-Hodjegan A; Turner DB
Biopharm Drug Dispos; 2017 Mar; 38(2):94-114. PubMed ID: 28214380
[TBL] [Abstract][Full Text] [Related]
13. A Sensitive Medium-Throughput Method to Predict Intestinal Absorption in Humans Using Rat Intestinal Tissue Segments.
Da Silva LC; Da Silva TL; Antunes AH; Rezende KR
J Pharm Sci; 2015 Sep; 104(9):2807-12. PubMed ID: 25690454
[TBL] [Abstract][Full Text] [Related]
14. Biliary excretion of the vasopressin analogue DDAVP after intraduodenal, intrajugular and intraportal administration in the conscious pig.
Lundin S; Pierzynovski SG; Weström BR; Bengtsson HI
Pharmacol Toxicol; 1991 Mar; 68(3):177-80. PubMed ID: 2057448
[TBL] [Abstract][Full Text] [Related]
15. The use of dietary-restricted rat intestine for active transport studies.
Neale RJ; Wiseman G
J Physiol; 1969 Nov; 205(1):159-78. PubMed ID: 5347715
[TBL] [Abstract][Full Text] [Related]
16. Enhanced permeability of insulin across the rat intestinal membrane by various absorption enhancers: their intestinal mucosal toxicity and absorption-enhancing mechanism of n-lauryl-beta-D-maltopyranoside.
Uchiyama T; Sugiyama T; Quan YS; Kotani A; Okada N; Fujita T; Muranishi S; Yamamoto A
J Pharm Pharmacol; 1999 Nov; 51(11):1241-50. PubMed ID: 10632081
[TBL] [Abstract][Full Text] [Related]
17. Preparation, purification, and characterization of a reversibly lipidized desmopressin with potentiated anti-diuretic activity.
Wang J; Shen D; Shen WC
Pharm Res; 1999 Nov; 16(11):1674-9. PubMed ID: 10571271
[TBL] [Abstract][Full Text] [Related]
18. [Permeabilities of rebamipide via different intestinal mucosa in the diffusion chamber in vitro].
Li GF; Wang CX; Yan Y; Kishimoto N; Yamamoto A
Yao Xue Xue Bao; 2008 Mar; 43(3):314-7. PubMed ID: 18630271
[TBL] [Abstract][Full Text] [Related]
19. Effect of food intake on the pharmacokinetics and antidiuretic activity of oral desmopressin (DDAVP) in hydrated normal subjects.
Rittig S; Jensen AR; Jensen KT; Pedersen EB
Clin Endocrinol (Oxf); 1998 Feb; 48(2):235-41. PubMed ID: 9579238
[TBL] [Abstract][Full Text] [Related]
20. Paracellular calcium transport across the small intestine.
Karbach U
J Nutr; 1992 Mar; 122(3 Suppl):672-7. PubMed ID: 1542029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
